The mechanisms behind Alzheimer's disease are not yet fully described, and changes in the electrophysiology of patients across the continuum of the disease could help to understand them. In this work, we study the power spectral distribution of a set of 129 individuals from the Connectomics of Brian Aging and Dementia project.
From this sample, we acquired task-free data, with eyes closed, and estimated the power spectral distribution in source space. We compared the spectral profiles of three groups of individuals: 70 healthy controls, 27 patients with amnestic MCI, and 32 individuals showing cognitive impairment without subjective complaints (IWOC).
The results showed a slowing of the brain activity in the aMCI patients, when compared to both the healthy controls and the IWOC individuals. These differences appeared both as a decrease in power for high frequency oscillations and an increase in power in alpha oscillations. The slowing of the spectrum was significant mainly in parietal and medial frontal areas.
We were able to validate the slowing of the brain activity in individuals with aMCI, appearing in our sample in areas related to the default mode network. However, this pattern did not appear in the IWOC individuals, suggesting that their condition is not part of the AD continuum. This work raises interesting questions about this group of individuals, and the underlying brain mechanisms behind their cognitive impairment.
TheisKASteinwegAHelmickCGCourtney-LongEBolenJALeeR. Which one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. Disabil Health J. 2019;12(3):411-421. doi:10.1016/j.dhjo.2019.03.001
2.
FinderVH. Alzheimer's disease: a general introduction and pathomechanism. J Alzheimer's Dis. 2010;22(SUPPL. 3):S5-S19. doi:10.3233/JAD-2010-100975
3.
CRJTMTSDW, et al.Prevalence of biologically vs clinically defined Alzheimer Spectrum entities using the national institute on aging-Alzheimer's Association research framework. JAMA Neurol. 2019;76(10):1174-1183. doi:10.1001/jamaneurol.2019.1971
4.
HanseeuwBJBetenskyRAJacobsHIL, et al.Association of amyloid and Tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915-294. doi:10.1001/jamaneurol.2019.1424
5.
PetersenRCLopezOArmstrongMJ, et al.Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology. Neurology. 2018;90(3):126-135. doi:10.1212/WNL.0000000000004826
6.
KasperSBancherCEckertA, et al.Management of mild cognitive impairment (MCI): the need for national and international guidelines. World J Biol Psychiatry. 2020;21(8):579-594. doi:10.1080/15622975.2019.1696473
7.
PandyaSYClemMASilvaLMWoonFL. Does mild cognitive impairment always lead to dementia? A review. J Neurol Sci. 2016;369:57-62. doi:10.1016/j.jns.2016.07.055
8.
GiannakopoulosPMissonnierPKövariEGoldGMichonA. Electrophysiological markers of rapid cognitive decline in mild cognitive impairment. Front Neurol Neurosci. 2009;24:39-46. doi:10.1159/000197898
9.
BabiloniCArakakiXAzamiH, et al.Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: recommendations of an expert panel. Alzheimer's Dement. April 2021;17(9):1528-1553. doi:10.1002/alz.12311
10.
López-SanzDSerranoNMaestúF. The role of magnetoencephalography in the early stages of Alzheimer’s disease. Front Neurosci. 2018;12:572. doi:10.3389/fnins.2018.00572
11.
CohenADBruñaRChangY-F, et al.Connectomics in brain aging and dementia – the background and design of a study of a connectome related to human disease. Front Aging Neurosci. 2021;13:669490. doi:10.3389/fnagi.2021.669490
12.
LopezOLBeckerJTKlunkWE, et al.Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II. Neurology. 2000;55(12):1863-1869. doi:10.1212/wnl.55.12.1863
13.
NasreddineZSPhillipsNABédirianV, et al.The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. doi:10.1111/j.1532-5415.2005.53221.x
14.
SaxtonJRatcliffGMunroCA, et al.Normative data on the Boston naming test and two equivalent 30-item short forms. Clin Neuropsychol. 2000;14(4):526-534. doi:10.1076/clin.14.4.526.7204
15.
WelshKAButtersNHughesJMohsRCHeymanA. Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol. 1991;48(3):278-281. doi:10.1001/archneur.1991.00530150046016
16.
WelshKAButtersNMohsRC, et al.The consortium to establish a registry for Alzheimer’s disease (CERAD). part V. A normative study of the neuropsychological battery. Neurology. 1994;44(4):609-614. doi:10.1212/wnl.44.4.609
17.
ReitanRM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271-276. doi:10.2466/PMS.8.7.271-276
18.
ReyA. L’examen psychologique dans les cas d’encéphalopathie traumatique. Arch Psychol (Geneve). 1941;28:215-285.
19.
GershonRCCellaDFoxNAHavlikRJHendrieHCWagsterMV. Assessment of neurological and behavioural function: the NIH toolbox. Lancet Neurol. 2010;9(2):138-139. doi:10.1016/S1474-4422(09)70335-7
20.
HowlandMTatsuokaCSmythKASajatovicM. Evaluating PROMIS(®) applied cognition items in a sample of older adults at risk for cognitive decline. Psychiatry Res. 2017;247:39-42. doi:10.1016/j.psychres.2016.10.072
21.
TauluSSimolaJ. Spatiotemporal signal space separation method for rejecting nearby interference in MEG measurements. Phys Med Biol. 2006;51(7):1759-1768. doi:10.1088/0031-9155/51/7/008
22.
BelouchraniAAbed-MeraimKCardosoJ-FMoulinesE. A blind source separation technique using second-order statistics. IEEE Trans Signal Process. 1997;45(2):434-444. doi:10.1109/78.554307
23.
OostenveldRFriesPMarisESchoffelenJ-M. Fieldtrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:1-9. doi:10.1155/2011/156869
24.
GarcésPLópez-SanzDMaestúFPeredaE. Choice of magnetometers and gradiometers after signal space separation. Sensors (Switzerland. 2017;17[12]:2926. doi:10.3390/s17122926
PennyWFristonKJAshburnerJKiebelSNicholsT. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Elsevier Ltd; 2007. doi:10.1016/B978-0-12-372560-8.X5000-1
27.
NolteG. The magnetic lead field theorem in the quasi-static approximation and its use for magnetoencephalography forward calculation in realistic volume conductors. Phys Med Biol. 2003;48(22):3637-3652. doi:10.1088/0031-9155/48/22/002
28.
Tzourio-MazoyerNLandeauBPapathanassiouD, et al.Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273-289. doi:10.1006/nimg.2001.0978
29.
van VeenBDvan DrongelenWYuchtmanMSuzukiA. Localization of brain electrical activity via linearly constrained minimum variance spatial filtering. IEEE Trans Biomed Eng. 1997;44(9):867-880. doi:10.1109/10.623056
30.
López-SanzDBruñaRGarcésP, et al.Alpha band disruption in the AD-continuum starts in the subjective cognitive decline stage: a MEG study. Sci Rep. 2016;6(1):37685. doi:10.1038/srep37685
31.
López-SanzDBruñaRDelgado-LosadaML, et al.Electro physiological brain signatures for the classification of subjective cognitive decline: towards an individual detection in the preclinical stages of dementia. Alzheimer’s Res Ther. 2019;11(1):49. doi:10.1186/s13195-019-0502-3
32.
de Frutos-LucasJCuestaPLópez-SanzD, et al.The relationship between physical activity, apolipoprotein e ɛ4 carriage, and brain health. Alzheimer’s Res Ther. 2020;12(1):48. doi:10.1186/s13195-020-00608-3
33.
MarisEOostenveldR. Nonparametric statistical testing of EEG- and MEG-data. J Neurosci Methods. 2007;164(1):177-190. doi:10.1016/j.jneumeth.2007.03.024
34.
LópezMECuestaPGarcésP, et al.MEG Spectral analysis in subtypes of mild cognitive impairment. Age (Dord.2014;36[3]: 9624. doi:10.1007/s11357-014-9624-5
35.
BerendseHWVerbuntJPAScheltensPvan DijkBWJonkmanEJ. Magnetoencephalographic analysis of cortical activity in Alzheimer’s disease: a pilot study. Clin Neurophysiol. 2000;111(4):604-612. doi:10.1016/S1388-2457(99)00309-0
36.
IshiiRCanuetLAokiY, et al.Healthy and pathological brain aging: from the perspective of oscillations, functional connectivity, and signal complexity. Neuropsychobiology. 2017;75(4): 151-161. doi:10.1159/000486870
37.
RaichleME. The brain’s default mode network. Annu Rev Neurosci. 2015;38(1):433-447. doi:10.1146/annurev-neuro-071013-014030
38.
WuXLiRFleisherAS, et al.Altered default mode network connectivity in Alzheimer’s disease-A resting functional MRI and bayesian network study. Hum Brain Mapp. 2011;32(11):1868-1881. doi:10.1002/hbm.21153
39.
DelbeuckXColletteFVan der LindenM. Is Alzheimer’s disease a disconnection syndrome?. evidence from a crossmodal audio-visual illusory experiment. Neuropsychologia. 2007;45(14):3315-3323. doi:10.1016/j.neuropsychologia.2007.05.001
40.
O’NeillGCBarrattELHuntBAETewariePKBrookesMJ. Measuring electrophysiological connectivity by power envelope correlation: a technical review on MEG methods. Phys Med Biol. 2015;60(21):R271-R295. doi:10.1088/0031-9155/60/21/R271
41.
LiuAKLLimEJAhmedIChangRC-CPearceRKBGentlemanSM. Review: revisiting the human cholinergic nucleus of the diagonal band of broca. Neuropathol Appl Neurobiol. 2018;44(7):647-662. doi:10.1111/nan.12513
42.
SenutMCMenetreyDLamourY. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical stu. Neuroscience. 1989;30(2):385-403. doi:10.1016/0306-4522(89)90260-1
43.
GrotheMHeinsenHTeipelSJ. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer’s disease. Biol Psychiatry. 2012;71(9):805-813. doi:10.1016/j.biopsych.2011.06.019
44.
BabiloniCDel PercioCCaroliA, et al.Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer’s disease: an EEG-PET study. Neurobiol Aging. 2016;48:122-134. doi:10.1016/j.neurobiolaging.2016.08.021
45.
JovicichJBabiloniCFerrariC, et al.Two-Year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer’s disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity. J Alzheimers Dis. 2019;69(1):15-35. doi:10.3233/JAD-180158
46.
SenBBCakirYSerap-SengorNMaguireLCoyleD. Model-based bifurcation and power spectral analyses of thalamocortical alpha rhythm slowing in Alzheimer’s disease. Neurocomputing. 2013;115:11-22. doi:10.1016/j.neucom.2012.10.023
47.
LiXYangXSunZ. Alpha rhythm slowing in a modified thalamo-cortico-thalamic model related with Alzheimer’s disease. PLoS One. 2020;15(3):e0229950. doi:10.1371/journal.pone.0229950
48.
FernándezAMaestúFAmoC, et al.Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography. Biol Psychiatry. 2002;52(7):764-770.
49.
PetersenRCDoodyRKurzA, et al.Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-1992. doi:nsa10002. [pii].
50.
EdmondsECDelano-WoodLGalaskoDRSalmonDPBondiMW. Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment. J Int Neuropsychol Soc. 2014;20(8):836-847. doi:10.1017/S135561771400068X
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
